Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .KAPPA.-CHAIN, DIMER

Advanced Triple Negative Breast Cancer (TNBC) With High TAMs

Novartis Pharmaceuticalsmonoclonal_antibodyPhase 2Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
43/ 100
Competitive Position
95/ 100

Competitive context

448 Active assets in the Advanced Triple Negative Breast Cancer (TNBC) With High TAMs cohort.

Asset / SponsorPhaseRating
Capivasertib
AstraZeneca
Phase 3BB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 4BB
Carboplatin
M.D. Anderson Cancer Center
Phase 4BB
Veliparib
National Cancer Institute (NCI)
Phase 3BB
Famitinib
Fudan University
Phase 3BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .KAPPA.-CHAIN, DIMER is also rated in:

endometrial carcinomaDormant
CC
Indicative ·
44 / 100
View asset →
metastatic carcinoma in the boneDormant
CC
Indicative ·
42 / 100
View asset →
exocrine pancreatic carcinomaDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →